CbdMD Historical Income Statement

YCBD Stock

USD 0.27 0 0.37%

Historical analysis of CbdMD income statement accounts such as Tax Provision of 0.0, Interest Income of 98.9 K, Interest Expense of 17.7 K or Total Revenue of 22.4 M can show how well cbdMD Inc performed in making a profits. Evaluating CbdMD income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CbdMD's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining cbdMD Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether cbdMD Inc is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About CbdMD Income Statement Analysis

cbdMD Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CbdMD shareholders. The income statement also shows CbdMD investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

CbdMD Income Statement Chart

At present, CbdMD's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 14.2 M, whereas Operating Income is projected to grow to (3.6 M).

Total Revenue Gross Profit Cost Of Revenue Other Operating Expenses Ebit

Total Revenue

Total revenue comprises all receipts cbdMD Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of cbdMD Inc minus its cost of goods sold. It is profit before CbdMD operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Cost Of Revenue

Cost of Revenue is found on cbdMD Inc income statement and represents the costs associated with goods and services CbdMD provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of cbdMD Inc. It is also known as CbdMD overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from CbdMD's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into cbdMD Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

	2022	2023	2024	2025 (projected)
Gross Profit	15.0M	12.0M	13.8M	14.2M
Total Revenue	24.2M	19.5M	22.4M	22.4M

Gross Profit Total Revenue

CbdMD income statement Correlations

	Tax Provision	Interest Income	Interest Expense	Total Revenue	Gross Profit	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Net Interest Income	Depreciation And Amortization	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Ebitda	Total Operating Expenses	Total Other Income Expense Net	Reconciled Depreciation	Discontinued Operations	Selling General Administrative	Extraordinary Items	Minority Interest	Selling And Marketing Expenses	Research Development
Tax Provision		0.11	-0.93	-0.52	-0.52	-0.1	-0.53	0.36	0.32	0.36	-0.32	-0.07	-0.57	0.32	-0.21	-0.24	-0.58	0.43	0.04	0.84	-0.87	0.48	0.16	-0.28	-0.3
Interest Income	0.11		-0.05	-0.18	-0.17	-0.01	-0.18	0.14	0.14	-0.04	-0.86	-0.22	-0.24	0.16	0.23	0.22	-0.24	0.07	-0.2	0.1	-0.18	0.21	0.21	-0.06	-0.11
Interest Expense	-0.93	-0.05		0.4	0.38	0.11	0.43	-0.19	-0.16	-0.32	0.28	-0.01	0.44	-0.15	0.3	0.33	0.44	-0.3	-0.17	-0.77	0.75	-0.39	-0.1	0.12	0.02
Total Revenue	-0.52	-0.18	0.4		1.0	-0.05	1.0	-0.46	-0.45	0.24	0.46	0.84	0.98	-0.41	-0.52	-0.46	0.98	-0.2	0.74	-0.52	0.85	-0.9	-0.87	0.06	0.31
Gross Profit	-0.52	-0.17	0.38	1.0		-0.07	0.99	-0.45	-0.44	0.22	0.44	0.83	0.98	-0.41	-0.54	-0.48	0.98	-0.19	0.73	-0.5	0.85	-0.89	-0.86	0.08	0.35
Operating Income	-0.1	-0.01	0.11	-0.05	-0.07		-0.02	-0.75	-0.76	-0.08	0.04	0.0	-0.02	-0.76	0.33	0.35	-0.01	-0.82	0.09	-0.34	0.11	-0.05	0.12	0.17	-0.09
Cost Of Revenue	-0.53	-0.18	0.43	1.0	0.99	-0.02		-0.47	-0.46	0.27	0.48	0.85	0.98	-0.42	-0.49	-0.42	0.97	-0.22	0.74	-0.55	0.86	-0.92	-0.88	0.01	0.24
Income Before Tax	0.36	0.14	-0.19	-0.46	-0.45	-0.75	-0.47		1.0	0.01	-0.29	-0.45	-0.5	1.0	0.04	-0.01	-0.51	0.91	-0.54	0.58	-0.54	0.49	0.31	-0.33	-0.31
Net Income	0.32	0.14	-0.16	-0.45	-0.44	-0.76	-0.46	1.0		-0.01	-0.28	-0.46	-0.49	1.0	0.07	0.01	-0.5	0.9	-0.55	0.54	-0.51	0.48	0.31	-0.33	-0.3
Income Tax Expense	0.36	-0.04	-0.32	0.24	0.22	-0.08	0.27	0.01	-0.01		0.24	0.59	0.16	0.02	-0.04	0.02	0.13	0.05	0.66	-0.07	-0.02	-0.52	-0.65	-0.87	-0.62
Net Interest Income	-0.32	-0.86	0.28	0.46	0.44	0.04	0.48	-0.29	-0.28	0.24		0.45	0.48	-0.28	-0.14	-0.09	0.47	-0.22	0.41	-0.41	0.46	-0.53	-0.46	-0.13	-0.02
Depreciation And Amortization	-0.07	-0.22	-0.01	0.84	0.83	0.0	0.85	-0.45	-0.46	0.59	0.45		0.8	-0.43	-0.61	-0.53	0.78	-0.16	0.97	-0.27	0.52	-0.86	-0.95	-0.21	0.04
Other Operating Expenses	-0.57	-0.24	0.44	0.98	0.98	-0.02	0.98	-0.5	-0.49	0.16	0.48	0.8		-0.46	-0.53	-0.47	1.0	-0.25	0.69	-0.54	0.89	-0.88	-0.83	0.14	0.38
Net Income From Continuing Ops	0.32	0.16	-0.15	-0.41	-0.41	-0.76	-0.42	1.0	1.0	0.02	-0.28	-0.43	-0.46		0.04	-0.01	-0.48	0.91	-0.52	0.54	-0.49	0.45	0.28	-0.34	-0.31
Ebit	-0.21	0.23	0.3	-0.52	-0.54	0.33	-0.49	0.04	0.07	-0.04	-0.14	-0.61	-0.53	0.04		1.0	-0.53	-0.36	-0.52	-0.4	-0.13	0.27	0.53	-0.32	-0.49
Ebitda	-0.24	0.22	0.33	-0.46	-0.48	0.35	-0.42	-0.01	0.01	0.02	-0.09	-0.53	-0.47	-0.01	1.0		-0.47	-0.41	-0.44	-0.46	-0.07	0.18	0.45	-0.36	-0.52
Total Operating Expenses	-0.58	-0.24	0.44	0.98	0.98	-0.01	0.97	-0.51	-0.5	0.13	0.47	0.78	1.0	-0.48	-0.53	-0.47		-0.26	0.67	-0.54	0.89	-0.86	-0.81	0.18	0.42
Total Other Income Expense Net	0.43	0.07	-0.3	-0.2	-0.19	-0.82	-0.22	0.91	0.9	0.05	-0.22	-0.16	-0.25	0.91	-0.36	-0.41	-0.26		-0.27	0.7	-0.45	0.33	0.05	-0.21	-0.12
Reconciled Depreciation	0.04	-0.2	-0.17	0.74	0.73	0.09	0.74	-0.54	-0.55	0.66	0.41	0.97	0.69	-0.52	-0.52	-0.44	0.67	-0.27		-0.25	0.42	-0.81	-0.89	-0.24	0.04
Discontinued Operations	0.84	0.1	-0.77	-0.52	-0.5	-0.34	-0.55	0.58	0.54	-0.07	-0.41	-0.27	-0.54	0.54	-0.4	-0.46	-0.54	0.7	-0.25		-0.83	0.67	0.34	0.08	0.01
Selling General Administrative	-0.87	-0.18	0.75	0.85	0.85	0.11	0.86	-0.54	-0.51	-0.02	0.46	0.52	0.89	-0.49	-0.13	-0.07	0.89	-0.45	0.42	-0.83		-0.81	-0.6	0.15	0.31
Extraordinary Items	0.48	0.21	-0.39	-0.9	-0.89	-0.05	-0.92	0.49	0.48	-0.52	-0.53	-0.86	-0.88	0.45	0.27	0.18	-0.86	0.33	-0.81	0.67	-0.81		0.92	0.28	0.01
Minority Interest	0.16	0.21	-0.1	-0.87	-0.86	0.12	-0.88	0.31	0.31	-0.65	-0.46	-0.95	-0.83	0.28	0.53	0.45	-0.81	0.05	-0.89	0.34	-0.6	0.92		0.34	0.04
Selling And Marketing Expenses	-0.28	-0.06	0.12	0.06	0.08	0.17	0.01	-0.33	-0.33	-0.87	-0.13	-0.21	0.14	-0.34	-0.32	-0.36	0.18	-0.21	-0.24	0.08	0.15	0.28	0.34		0.87
Research Development	-0.3	-0.11	0.02	0.31	0.35	-0.09	0.24	-0.31	-0.3	-0.62	-0.02	0.04	0.38	-0.31	-0.49	-0.52	0.42	-0.12	0.04	0.01	0.31	0.01	0.04	0.87

Click cells to compare fundamentals

CbdMD Account Relationship Matchups

CbdMD income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	71.9M	57.7M	28.9K	16.2K	18.7K	17.7K
Total Revenue	44.5M	35.4M	24.2M	19.5M	22.4M	22.4M
Gross Profit	30.0M	22.3M	15.0M	12.0M	13.8M	14.2M
Operating Income	(19.6M)	35.8M	(9.3M)	(3.3M)	(3.8M)	(3.6M)
Cost Of Revenue	14.5M	13.1M	9.2M	7.5M	8.6M	8.2M
Income Before Tax	(24.3M)	(70.1M)	(22.9M)	(3.7M)	(3.3M)	(3.5M)
Net Income Applicable To Common Shares	(50.4M)	12.2M	(25.9M)	(74.1M)	(66.7M)	(63.3M)
Net Income	(23.4M)	(74.1M)	(22.9M)	(3.7M)	(3.3M)	(3.5M)
Income Tax Expense	(1.3M)	(895K)	4.0M	13.7M	15.7M	16.5M
Net Interest Income	(28.9K)	16.2K	63.7K	(29.5K)	(33.9K)	(35.6K)
Depreciation And Amortization	2.3M	3.0M	2.9M	1.8M	2.1M	1.5M
Other Operating Expenses	64.1M	52.6M	33.4M	22.8M	26.2M	35.3M
Net Income From Continuing Ops	(23.4M)	(70.1M)	(22.9M)	(3.7M)	(3.3M)	(3.5M)
Ebit	(24.3M)	(18.4M)	(10.4M)	(3.3M)	(3.0M)	(3.1M)
Ebitda	(22.0M)	(15.5M)	(7.5M)	(1.5M)	(1.3M)	(1.4M)
Total Operating Expenses	49.6M	39.6M	24.2M	15.3M	17.6M	26.2M
Total Other Income Expense Net	(4.7M)	(52.8M)	(13.7M)	(384.7K)	(346.2K)	(363.6K)
Reconciled Depreciation	2.3M	3.0M	2.9M	1.8M	2.1M	1.6M
Selling General Administrative	21.8M	15.8M	9.6M	8.4M	7.6M	12.5M
Selling And Marketing Expenses	17.6M	15.4M	7.0M	4.2M	3.8M	3.6M
Research Development	1.4M	633.4K	173.0K	39.0K	35.1K	33.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:

How To Invest In CbdMD

Details

Is CbdMD Stock a good investment?

Details

What is CbdMD's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(10.90)

Revenue Per Share

7.06

Quarterly Revenue Growth

(0.15)

Return On Assets

(0.16)

Return On Equity

(1.35)

The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CbdMD Historical Income Statement

About CbdMD Income Statement Analysis

CbdMD Income Statement Chart

Total Revenue

Gross Profit

Cost Of Revenue

Other Operating Expenses

CbdMD income statement Correlations

CbdMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CbdMD income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Net Income	+ 1.0	Income Before Tax
Net Income From Continuing Ops	+ 1.0	Income Before Tax
Net Income From Continuing Ops	+ 1.0	Net Income
Total Operating Expenses	+ 1.0	Other Operating Expenses

Minority Interest	- 0.95	Depreciation And Amortization
Interest Expense	- 0.93	Tax Provision
Extraordinary Items	- 0.92	Cost Of Revenue
Extraordinary Items	- 0.9	Total Revenue
Minority Interest	- 0.89	Reconciled Depreciation
Extraordinary Items	- 0.89	Gross Profit